List of works - Sohji Nishina

A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice ⬇️

scientific article published on February 15, 2011

Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging

scientific article published on 10 May 2016

Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice

scientific article published on 18 September 2014

Clinical usefulness of non‐protein respiratory quotient measurement in non‐alcoholic fatty liver disease ⬇️

scientific article published on March 19, 2013

Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice

scientific article published on 11 September 2018

Factors predicting incomplete endoscopic hemostasis in bleeding gastroduodenal ulcers

scientific article published on May 2010

Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma

scientific article published on 2 September 2015

Focal Nodular Hyperplasia-Like Nodule with Reduced Expression of Organic Anion Transporter 1B3 in Alcoholic Liver Cirrhosis ⬇️

scientific article published on January 1, 2011

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection

scientific article

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

scientific article

HCV and oxidative stress

scientific article published on 01 May 2011

Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein

scientific article published in June 2006

Hepatic oxidative stress in ovariectomized transgenic mice expressing the hepatitis C virus polyprotein is augmented through suppression of adenosine monophosphate-activated protein kinase/proliferator-activated receptor gamma co-activator 1 alpha s

scientific article published on 14 November 2013

Hepatitis C virus core protein suppresses mitophagy by interacting with parkin in the context of mitochondrial depolarization

scientific article

Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice

scientific article published in March 2010

Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription

scientific article published on 9 October 2007

Iron loss triggers mitophagy through induction of mitochondrial ferritin

scientific article published on 25 September 2020

Iron metabolic disorder in chronic hepatitis C: insights from recent evidence

scientific article published on 31 July 2012

Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis

scientific article published on December 2013

Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine.

scientific article

Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication

scientific article

Mitochondrial reactive oxygen species as a mystery voice in hepatitis C.

scientific article published on 08 January 2014

Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice

scientific article published on 24 October 2020

Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010.

scientific article

Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis

scientific article published on 15 July 2013

Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein

scientific article published in August 2007

Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

scientific article published on 26 April 2011

Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

scientific article published on 7 January 2018

[Hepatocarcinogenesis and iron metabolic disorder]

scientific article published on 01 April 2012

List of works by Sohji Nishina

A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice ⬇️

Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging

Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice

Clinical usefulness of non‐protein respiratory quotient measurement in non‐alcoholic fatty liver disease ⬇️

Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice

Factors predicting incomplete endoscopic hemostasis in bleeding gastroduodenal ulcers

Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma

Focal Nodular Hyperplasia-Like Nodule with Reduced Expression of Organic Anion Transporter 1B3 in Alcoholic Liver Cirrhosis ⬇️

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

HCV and oxidative stress

Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein

Hepatic oxidative stress in ovariectomized transgenic mice expressing the hepatitis C virus polyprotein is augmented through suppression of adenosine monophosphate-activated protein kinase/proliferator-activated receptor gamma co-activator 1 alpha s

Hepatitis C virus core protein suppresses mitophagy by interacting with parkin in the context of mitochondrial depolarization

Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice

Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription

Iron loss triggers mitophagy through induction of mitochondrial ferritin

Iron metabolic disorder in chronic hepatitis C: insights from recent evidence

Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis

Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine.

Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication

Mitochondrial reactive oxygen species as a mystery voice in hepatitis C.

Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice

Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010.

Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis

Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein

Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

[Hepatocarcinogenesis and iron metabolic disorder]

[Molecular mechanisms underlying iron metabolic disorder in hepatitis C]